As companies around the globe race to develop a COVID-19 vaccine and nations scramble to secure millions of doses, questions about the use of pork-derived ingredients has begun to play a role in the purchasing and planned distribution
As companies around the globe race to develop a COVID-19 vaccine and nations scramble to secure millions of doses, questions about the use of pork-derived ingredients has begun to play a role in the purchasing and planned distribution